Youran Zhang; Lili Wang; Zhen Jiang; Hongjing Yan; Xiaoxia Liu; Jing Gu; Guoyong Wang; Xiaosong Cheng; Qiyan Leng; Qisui Long; Zimian Liang; Jing Wang; Liang Liang; Yanchao Qiu; Lin Chen; Hang Hong; Youran Zhang; Lili Wang; Zhen Jiang; Hongjing Yan; Xiaoxia Liu; Jing Gu; Guoyong Wang; Xiaosong Cheng; Qiyan Leng; Qisui Long; Zimian Liang; Jing Wang; Liang Liang; Yanchao Qiu; Lin Chen; Hang Hong

doi:10.46234/ccdcw2024.089

[1]

Kripke K, Eakle R, Cheng A, Rana S, Torjesen K, Stover J. The case for prevention - Primary HIV prevention in the era of universal test and treat: a mathematical modeling study. EClinicalMedicine 2022;46:101347.

[2]

Kapiriri L, Lee NM, Wallace LJ, Kwesiga B. Beyond cost-effectiveness, morbidity and mortality: a comprehensive evaluation of priority setting for HIV programming in Uganda. BMC Public Health 2019;19(1):359.

[3]

Atun R, Chang AY, Ogbuoji O, Silva S, Resch S, Hontelez J, et al. Long-term financing needs for HIV control in sub-Saharan Africa in 2015-2050: a modelling study. BMJ Open 2016;6(3):e009656.

[4]

Kasaie P, Weir B, Schnure M, Dun C, Pennington J, Teng Y, et al. Integrated screening and treatment services for HIV, hypertension and diabetes in Kenya: assessing the epidemiological impact and cost-effectiveness from a national and regional perspective. J Int AIDS Soc 2020;23 Suppl 1(Suppl 1):e25499. http://dx.doi.org/10.1002/jia2.25499.

[5]

Zhang YR, Wang LL, Jiang Z, Yan HJ, Liu XX, Gu J, et al. Estimating costs of the HIV comprehensive intervention using the spectrum model - China, 2015-2019. China CDC Wkly 2022;4(25):554 − 9.

[6]

The People’s Bank of China. Chart of CNY exchange rate midpoint. http://www.pbc.gov.cn/rmyh/108976/109428/index.html. [2022-6-26]. (in Chinese).

[7]

Sahu D, Kumar P, Chandra N, Rajan S, Shukla DK, Venkatesh S, et al. Findings from the 2017 HIV estimation round & trend analysis of key indicators 2010-2017: evidence for prioritising HIV/AIDS programme in India. Indian J Med Res 2020;151(6):562 − 70.

[8]

Sundararajan R, Ponticiello M, Nansera D, Jeremiah K, Muyindike W. Interventions to increase HIV testing uptake in global settings. Curr HIV/AIDS Rep 2022;19(3):184 − 93.

[9]

Colvin CJ. Strategies for engaging men in HIV services. Lancet HIV 2019;6(3):e191 − 200.

[10]

Yeh PT, Kennedy CE, Minamitani A, Baggaley R, Shah P, Verster A, et al. Web-based service provision of HIV, viral hepatitis, and sexually transmitted infection prevention, testing, linkage, and treatment for key populations: systematic review and meta-analysis. J Med Internet Res 2022;24(12):e40150.

[11]

Reitsema M, van Hoek AJ, van der Loeff MS, Hoornenborg E, van Sighem A, Wallinga J, et al. Preexposure prophylaxis for men who have sex with men in the Netherlands: impact on HIV and Neisseria gonorrhoeae transmission and cost-effectiveness. AIDS 2020;34(4):621 − 30.

[12]

Celum C, Baeten JM. Lessons on PrEP from the SEARCH study in east Africa. Lancet HIV 2020;7(4):e219 − 20.

[13]

Leech AA, Burgess JF, Sullivan M, Kuohung W, Horný M, Drainoni ML, et al. Cost-effectiveness of preexposure prophylaxis for HIV prevention for conception in the United States. AIDS 2018;32(18):2787 − 98.

[14]

Jijón S, Molina JM, Costagliola D, Supervie V, Breban R. Can HIV epidemics among MSM be eliminated through participation in preexposure prophylaxis rollouts? AIDS 2021;35(14):2347-54. http://dx.doi.org/10.1097/QAD.0000000000003012.

[15]

Stover J, Glaubius R, Kassanjee R, Dugdale CM. Updates to the spectrum/AIM model for the UNAIDS 2020 HIV estimates. J Int AIDS Soc 2021;24 Suppl 5(Suppl 5):e25778. http://dx.doi.org/10.1002/jia2.25778.